UroGen Pharma Ltd. (URGN)
43.06
-0.56
(-1.28%)
USD |
NASDAQ |
Aug 31, 16:00
43.06
0.00 (0.00%)
After-Hours: 20:00
UroGen Pharma Price to Book Value
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| December 30, 2024 | 17.40 |
| December 27, 2024 | 17.79 |
| December 26, 2024 | 18.26 |
| December 24, 2024 | 17.89 |
| December 23, 2024 | 17.71 |
| December 20, 2024 | 17.59 |
| December 19, 2024 | 17.71 |
| December 18, 2024 | 17.84 |
| December 17, 2024 | 18.74 |
| December 16, 2024 | 18.69 |
| December 13, 2024 | 18.77 |
| December 12, 2024 | 18.97 |
| December 11, 2024 | 18.92 |
| December 10, 2024 | 19.91 |
| December 09, 2024 | 20.12 |
| December 06, 2024 | 20.32 |
| December 05, 2024 | 20.19 |
| December 04, 2024 | 20.60 |
| December 03, 2024 | 20.41 |
| December 02, 2024 | 21.30 |
| November 29, 2024 | 21.00 |
| November 27, 2024 | 20.93 |
| November 26, 2024 | 20.64 |
| November 25, 2024 | 20.64 |
| November 22, 2024 | 19.69 |
| Date | Value |
|---|---|
| November 21, 2024 | 19.10 |
| November 20, 2024 | 18.93 |
| November 19, 2024 | 18.45 |
| November 18, 2024 | 18.26 |
| November 15, 2024 | 18.50 |
| November 14, 2024 | 19.61 |
| November 13, 2024 | 20.11 |
| November 12, 2024 | 20.42 |
| November 11, 2024 | 21.15 |
| November 08, 2024 | 20.04 |
| November 07, 2024 | 20.01 |
| November 06, 2024 | 20.24 |
| November 05, 2024 | 20.19 |
| November 04, 2024 | 19.73 |
| November 01, 2024 | 20.17 |
| October 31, 2024 | 20.27 |
| October 30, 2024 | 21.53 |
| October 29, 2024 | 20.26 |
| October 28, 2024 | 20.09 |
| October 25, 2024 | 20.01 |
| October 24, 2024 | 20.01 |
| October 23, 2024 | 20.06 |
| October 22, 2024 | 20.62 |
| October 21, 2024 | 20.70 |
| October 18, 2024 | 21.05 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Insmed, Inc. | 35.13 |
| Xencor, Inc. | 4.025 |
| MeiraGTx Holdings Plc | 6.032 |
| IDEAYA Biosciences, Inc. | 3.223 |
| ACADIA Pharmaceuticals, Inc. | 3.809 |
Price to Book Value Related Metrics
| PS Ratio | 11.23 |
| Price | 43.06 |
| Earnings Yield | -4.63% |
| Market Cap | 2.104B |